Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
eculizumab
eculizumab
Brand names: Soliris
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS | 10 mg/mL |
Last updated: May. 24, 2024
- Black Box Warning: Meningococcal Infection
- REMS: Soliris Injection
- Restricted Restricted Medication
This medication is Inpatient Non-formulary and Restricted to Outpatient Use. Inpatient use requires approval by a physician department leader (i.e. Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.
See HERE for more information and workflow.
See HERE for additional pharmacy workflow details.